电子邮件 | ema***@***.com | 获取Email |
---|
电子邮件 | ema***@***.com | 获取Email |
---|
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal's lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com.
公司 | Madrigal Pharmaceuticals |
---|---|
职位 | Vice President Clinical Development |
地点 | United States |
http://www.linkedin.com/in/david-schneider-md-mba-31aa68b | |
部门 | |
头衔 | Vice President Clinical Development at Madrigal Pharmaceuticals |
Madrigal Pharmaceuticals Vice President Clinical Development
2021-08-01 -
Medpace Vice President Medical Department
2018-11-01 - 2021-03-01
INC Research Vice President, Medical Affairs
2016-06-01 - 2018-11-01
INC Research Executive Medical Director
2014-07-01 - 2016-06-01
INC Research Senior Medical Director
2012-03-01 - 2014-07-01
David Schneider 在 Madrigal Pharmaceuticals 担任 Vice President Clinical Development at Madrigal Pharmaceuticals
David Schneider 在 Madrigal Pharmaceuticals 的职位是 Vice President Clinical Development at Madrigal Pharmaceuticals
David Schneider 的电子邮件地址是 ema***@***.com
David Schneider 的电话号码是 -
David Schneider 的公司电话号码是 +161****
David Schneider 在 pharmaceuticals 工作。
David Schneider 的一些同事包括Erin Hrobak、Mark Ferguson、Alexandre Felizardo、David SchneiderChristy Hewitt、。
David Schneider联系方式: 电子邮件地址:ema***@***.com 电话号码:-
David Schneider 的个人领英是:http://www.linkedin.com/in/david-schneider-md-mba-31aa68b
David Schneider 的办公地点:200 Barr-Harbor Dr, Suite 200, Conshohocken, Pennsylvania 19428, US
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd